O. Baser Et Al. , "ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY," VALUE IN HEALTH , vol.17, no.7, 2014
Baser, O. Et Al. 2014. ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY. VALUE IN HEALTH , vol.17, no.7 .
Baser, O., Kariburyo, M. F., Altinbas, A., & Baser, E., (2014). ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY. VALUE IN HEALTH , vol.17, no.7.
Baser, O. Et Al. "ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY," VALUE IN HEALTH , vol.17, no.7, 2014
Baser, O. Et Al. "ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY." VALUE IN HEALTH , vol.17, no.7, 2014
Baser, O. Et Al. (2014) . "ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY." VALUE IN HEALTH , vol.17, no.7.
@article{article, author={O. Baser Et Al. }, title={ECONOMIC BURDEN AND COMPLICATIONS OF HEPATITIS C VIRUS PATIENTS WITH AND WITHOUT PEGINTERFERON AND RIBAVIRIN TREATMENT IN TURKEY}, journal={VALUE IN HEALTH}, year=2014}